Diagram of response and relapse to cycle no. 1 and response to cycle no. 2 in patients with HCL treated with 2-CdA.^* One of the 25 patients was treated with rituximab (CR), and one of 25 was retreated with 2′-DCF (CR). † One (4%) of 23 patients' responses remains to be determined.